ReviewJournal of inflammation research2026
Lipid Metabolism in Regulatory T Cells in Health and Disease.
Review in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Regulatory T cells (Tregs) play a central role in controlling immune responses. Forkhead box protein 3 (FOXP3) is a master transcription factor essential for differentiation and suppression. Recently, distinct metabolic statuses of Tregs under both physiological and pathological conditions have been reported. This review aimed to summarize lipid metabolism in Tregs. Compared to other immune cells, the increased oxidative phosphorylation and fatty acid oxidation are unique, and this metabolic profile shapes Treg-specific metabolites, including lipids. To support this unique lipid metabolism, enrichment of mitochondria has been suggested in Tregs. Other organelles, including lysosomes and peroxisomes, have been reported to interact, and crosstalk between them may facilitate preferential lipid metabolism in Tregs. In addition to their role in physiological lipid metabolism, associations between autoimmunity and tumor microenvironment have been demonstrated in various diseases. A deeper understanding of lipid metabolism in Tregs in both healthy and diseased conditions may enhance therapeutic strategies for autoimmunity and cancers, including solid tumors. In conclusion, the unique lipid metabolism of Tregs can be utilized for immunotherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.